Holdings
Siren, L.L.C.
As of Sep 30, 2026, Siren, L.L.C. reported 96 positions worth US$4.06B. Largest: Scholar Rock Holding Corporation, Kymera Therapeutics, Inc. and Erasca, Inc. What it bought and sold, with each filing.
| Company | Shares | Value as reported | Change | As of |
|---|---|---|---|---|
| Scholar Rock Holding Corporation | 9.38M | US$453M | −200K | Sep 30, 2026 |
| Kymera Therapeutics, Inc. | 2.78M | US$311M | −151K | Sep 30, 2026 |
| Erasca, Inc. | 13.2M | US$193M | +1.8M | Sep 30, 2026 |
| Revolution Medicines, Inc. | 850K | US$174M | −50,000 | Sep 30, 2026 |
| BeOne Medicines Ltd. Class A | 465K | US$170M | no change | Sep 30, 2026 |
| Tango Therapeutics, Inc. | 6.78M | US$169M | +605K | Sep 30, 2026 |
| Veradermics, Incorporated | 1.32M | US$161M | −331K | Sep 30, 2026 |
| Arrowhead Pharmaceuticals, Inc. | 2.29M | US$150M | +575K | Sep 30, 2026 |
| Edgewise Therapeutics, Inc. | 2.8M | US$114M | −380K | Sep 30, 2026 |
| Rhythm Pharmaceuticals, Inc. | 1.09M | US$103M | −50,000 | Sep 30, 2026 |